Sponsor pipeline

Convergent Therapeutics clinical trial pipeline

Get alerts when Convergent Therapeutics's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor

    Primary completion pushed from Apr 20, 2027 to Aug 2027

    Also in this update: Study completion pushed from Apr 20, 2027 to Oct 2031

    Convergent TherapeuticsPhase 2 NCT06549465 Registry history

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 2
1

Disease areas by active trials

Prostate Cancer (1)

Get alerts when Convergent Therapeutics's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free